Abstract
Purpose: MET amplification is a frequent mechanism of resistance to EGFR tyrosine kinase inhibitors (TKI) in patients with EGFR-mutated non-small cell......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
